Study Stopped
Covid-19 pandemic hindered the group based intervention
Mindfulness Based Stress Reduction for Intellectually Able Autistic Adults
1 other identifier
interventional
140
0 countries
N/A
Brief Summary
This project evaluates mindfulness based stress-reduction (MBSR), adjusted and manualized for intellectually able autistic adults. MBSR is a skills training program based on further development of cognitive behavioral therapy. The program includes eight weekly group training sessions and one full-day retreat, aiming at stress reduction and improved coping in everyday life, as well as improved mental health. The aspiration is to make ASD-adjusted MBSR an intervention that is acceptable and accessible to individuals with autism in open clinical care. This includes considering variability in background factors such as age, comorbidity and other personal qualities and preferences. The aim of the studies is to evaluate (1) the feasibility and (2) effectiveness of MBSR in adults (18 or over) with autism without intellectual disability, in an outpatient clinical habilitation context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2022
CompletedFirst Posted
Study publicly available on registry
February 17, 2022
CompletedMarch 8, 2022
February 1, 2022
5.7 years
February 8, 2022
February 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Study 1 (feasibility study): Treatment completion.
Participants attending six or more out of the total nine occasions (eight sessions and one retreat) (≥66%) were considered completers.
Immediately after intervention.
Study 1 (feasibility study): Credibility as measured by the Treatment Credibility Scale (TCS: Borkovec & Nau, 1972).
Five statements scored on a ten-point Likert scale where higher points indicate higher treatment credibility.
Baseline compared to immediately after intervention.
Study 2 (RCT): Perceived stress as measured by the Perceived stress scale (Cohen et al., 1983).
14 statements scored on a five-point Likert-scale (0-4) where higher points indicate higher perceived stress.
Change from baseline to immediately after the intervention.
Secondary Outcomes (9)
Study 1 (feasibility study): Perceived stress as measured by the Perceived stress scale (Cohen et al., 1983).
Baseline compared to immediately after intervention.
Study 1 (feasibility study): Symptoms of anxiety and depression as measured by Hospital anxiety and depression scale (HADS: the Swedish Lisspers et al., 1997; Zigmond & Snaith, 1983).
Baseline compared to immediately after intervention.
Study 1 (feasibility study): Satisfaction with life as measured by Satisfaction with life scale (SWLS: Diener et al., 1985).
Baseline compared to immediately after intervention.
Study 1 (feasibility study): Mindfulness, assessed by Mindful attention awareness scale (MAAS: Brown & Ryan, 2003).
Baseline compared to immediately after intervention.
Study 1 (feasibility study): Acceptance of the Autism diagnosis, assessed by a modified version of the Acceptance and action questionnaire (Bond et al., 2011) for ASD.
Baseline compared to immediately after intervention.
- +4 more secondary outcomes
Other Outcomes (1)
Study 1 (feasibility study and RCT): Adverse events and serious adverse events.
At any timepoint during or immediately after the intervention, i.e. not a measure that was assessed for all participants, but reported by any participant that felt he/she had experienced an adverse event.
Study Arms (2)
Mindfulness-based stress reduction (MBSR)
EXPERIMENTALThe 9 session MBSR program following the manual (Kabat-Zinn, 1982).
Treatment as usual (TAU)
ACTIVE COMPARATORParticipants take part in their treatment as usual in outpatient habilitation and other services.
Interventions
The 8 week (plus one-day retreat) manualized MBSR program according to the manual (Kabat-Zinn, 1982).
Different interventions and support in outpatient and other services.
Eligibility Criteria
You may qualify if:
- Diagnose within the autism spectrum according to ICD-10, DSM-IV or DSM-5.
- Minimum ≥18 years of age.
- Adequate knowledge of the Swedish language.
You may not qualify if:
- Intellectual disability (IQ≤70).
- Severe mental illnesses that would hinder participation (e.g. psychosis or acute risk for suicidal behaviors).
- Drug use in the last three months.
- Poor mental health as assessed with Montgomary Åsberg Depression Rating Scale (MADRS) in combination with semi-structured interview by a clinical psychologist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Open feasibility study: no masking. RCT: during the screening, assessment of eligibility and completion of T1 (baseline), the allocation to a specific study arm is masked. After T1, all participants, care provider and investigators know which arm (group or treatment as usual) was allocated.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 8, 2022
First Posted
February 17, 2022
Study Start
January 1, 2016
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
March 8, 2022
Record last verified: 2022-02